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ABSTRACT
Objective We evaluated the temporal trend in gender 
ratios of first and last authors in the field of oncological 
research published in major general medical and oncology 
journals and examined the gender pattern in coauthorship.
Design We conducted a retrospective study in PubMed 
using the R package RISmed. We retrieved original 
research articles published in four general medical 
journals and six oncology specialty journals. These journals 
were selected based on their impact factors and popularity 
among oncologists. We identified the names of first and 
last authors from 1 January 2002 to 31 December 2019. 
The gender of the authors was identified and validated 
using the Gender API database (https:// gender‑ api. com/).
Primary and secondary outcome measures The 
percentages of first and last authors by gender and the 
gender ratios (male to female) and temporal trends in 
gender ratios of first and last authors were determined.
Results We identified 34 624 research articles, in which 
32 452 had the gender of both first and last authors 
identified. Among these 11 650 (33.6%) had women as 
the first author and 7908 (22.8%) as the last author, 
respectively. The proportion of female first and last authors 
increased from 26.6% and 16.2% in 2002, to 32.9% 
and 27.5% in 2019, respectively. However, the gender 
ratio (male to female) of first and last authors decreased 
by 1.5% and 2.6% per year, respectively, which were 
statistically significant (first author: incidence rate ratio 
(IRR) 0.98, 95% CI 0.97 to 1.00; last author: IRR 0.97, 
95% CI 0.96 to 0.99). Male first and last authorship was 
the most common combination. Male–female and female–
female pairs increased by 2.0% and 5.0%, respectively 
(IRR 1.02, 95% CI 1.01 to 1.03 and IRR 1.05, 95% CI 1.04 
to 1.06, respectively).
Conclusions The continued under‑ representation of 
women means that more efforts to address parity for 
advancement of women in academic oncology are needed.
INTRODUCTION
Gender disparity is being increasingly 
identified in many disciplines, including 
oncology. In 2017, the Association of Amer-
ican Medical Colleges reported that women 
accounted for 33.3% and 27.2% of active 
US physicians in haematology- oncology and 
radiation oncology, respectively.1 Compared 
with men, women are also less likely to be 
the first authors in high- profile publications,2 
receive grant funding3 4 and be invited as 
peer reviewers.5
Systematic biases in academia and research 
institutions may possibly hinder their 
academic development.6 The possibility of 
unconscious bias against women in the peer 
review processes,7 the way women tend to 
promote and present their research find-
ings,8 and the often under- representation 
of women in the editorial boards of medical 
journals may make the journals less likely to 
prioritise research topics more commonly 
studied by women.9 10 However, publishing 
is important for building and maintaining a 
successful academic careers. It gives visibility 
to the author and provides a platform and 
opportunity for recognition as a researcher. It 
is not only the means through which research 
is communicated, but also a critical measure 
Strengths and limitations of this study
 ► We have performed extensive literature search and 
described the gender gap in original oncology re‑
search publications in 10 major medical journals 
over the last 18 years.
 ► Gender inference algorithms currently only support 
gender binary classification systems.
 ► We assessed the gender composition of first and last 
authors on the assumption that these authorship po‑
sitions are key positions in research activities and 
publication.
 ► Our analysis included only original research articles; 
other important contributions in research projects 
including conference abstracts for presentation, da‑
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of academic productivity and merit. The quantity and 
quality of publications are frequently used to assess job 
employment, tenure and promotion.11
Assessing the scientific publication trends in the field 
of oncology may highlight opportunities for improved 
awareness of the importance of gender parity, mentor-
ship, representation and advancement for women. The 
existing data about gender trends in academic publica-
tion in oncology often examine only a small subset of jour-
nals12 and include articles other than original research 
or oncology studies.13 14 Therefore, we aimed to extend 
the scientific evidence by examining the global trends in 
women’s representation as first and last authors of orig-




This study focused on original research articles published 
from 2002 to 2019 in select high- impact English- language 
journals. Journals were selected after consideration of 
relevant literature,15 16 impact factor, citation half- life and 
readership. Comments from faculty members regarding 
the long- term prestige and importance of the various 
journals were also collected. Four journals categorised by 
the Thomson Reuters International Scientific Indexing 
Journal Citation Index as general medical journals were 
included as follows: The New England Journal of Medicine, 
The Journal of the American Medical Association (JAMA), The 
Lancet and The BMJ. Six journals categorised as oncology 
journals were also included: Journal of Clinical Oncology, 
Journal of the National Cancer Institute, The Lancet Oncology, 
Cancer, International Journal of Radiation Oncology, Biology, 
Physics, and Radiotherapy and Oncology. These 10 clini-
cally orientated journals whose bibliographic citations 
include authors’ full first name were included. We used 
the database from Gender API (https:// gender- api. 
com/; Munich, Germany) to assign gender to first and 
last authors based on their first name. Their algorithm 
combined and verified data of multiple data sources, 
including publicly available governmental sources and 
social networks, to provide the best possible matches.
Search strategy
We developed a search query combining terms for 
journal names and cancer- related Medical Subject 
Heading terms. We focused on oncology- specific original 
research articles. Comments, editorials, review articles, 
retracted articles, errata biographies, personal narratives, 
portraits, introductory journal articles, practice guide-
lines, consensus development conferences, congresses 
and clinical conferences were excluded a priori using 
appropriate Medical Subject Heading terms for publi-
cation types. Guidelines, duplicate publications, legal 
cases, interviews and news articles were also excluded. We 
used the database from Gender API, which is a validated 
application programming interface for R to predict the 
probability of gender of an author’s first name, to allow 
assignment of gender to each first and last author. At the 
time of the study, the database of this program contains 1 
847 011 validated names from 177 different countries,17 
and prior study has demonstrated high reliability of this 
gender inference tool for all name origins, with the best 
features among the main gender inference services.18 We 
used a threshold for accuracy of more than 60% to assign 
gender based on the author’s first name, as has been 
implemented in previous works.12 19 20 We also excluded 
the assignation of genders when the sample of Gender 
API was less than 10 cases.
Statistical analysis
We first calculated the numbers and percentages of first 
and last authors who were women and men, respectively. 
Then, the percentages within each authorship position 
were calculated out of the total number of women and 
men authors. To understand the pattern of collaboration 
of first and last authors, we paired the first and last authors 
by gender to create four categories. These four categories 
are (1) male first–male last, (2) male first–female last, (3) 
female first–male last, and (4) female last–female last. 
To assess the overall temporal trends, we fitted Poisson 
regression models with the count of articles in gender 
ratios as a dependent variable and the year of publica-
tion as an independent variable. We presented the rates 
of change as the interaction between gender ratios as first 
and last author and the calendar years of publications for 
the whole period and contrasted them by journals. Addi-
tionally, we assessed the temporal trends in percentages 
of publications when analysed by gender pairs of first and 
last authors.
As a sensitivity analysis, using data published by the 
Association of American Medical Colleges,1 we compared 
the percentages of female first and last authors with 
those who are actively licensed female physicians and 
who worked in the haematology- oncology and radiation 
oncology practices in the USA. We also fitted separate 
logistic regression models with the gender of first and 
last authors of individual papers as a dependent variable 
and year of publication and the number of coauthors 
(per one increase, up to 10 authors) in each article as 
independent variables. Further, we analysed 47 jour-
nals in Q4 rank of oncology in 2020 and assessed the 
distribution of first and last author by gender. Finally, we 
analysed single- authored articles, computing the male 
to female ratio by year and for the period 2002–2019. All 
data analyses were completed using R V.3.6.1 (R Foun-
dation for Statistical Computing, Vienna, Austria), the 
RISmed package (V.2.1.12) to search in PubMed and 
Stata V.16.1. We provide the program codes to search 
the databases and run the analysis in online supple-
mental file 1.
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RESULTS
Of the 34 624 articles analysed, we identified 9332 unique 
names of first and last authors. Of all the articles analysed, 
gender was identified for both the first and last authors 
in 32 452 (94%). Out of 34 624 articles, 11 650 (33.6%) 
had women as the first author, while 7908 (22.8%) had 
women as the last author (p value both <0.001) (see 
table 1). Gender information was not available for 3.6% 
of the first authors and 3.0% of the last authors. This 
is similar to the 3.0% non- classified names achieved 
by Gender API in the benchmark of different gender 
assignments tools.18 As shown in table 2, the proportion 
of women first authors increased from 26.6% in 2002 to 
32.9% in 2019. Similarly, the proportion of women last 
authors increased from 16.2% in 2002 to 27.5% in 2019 
(p value for trend <0.001).
Figures 1 and 2 show changes in representation of 
women as first and last authors by year and journal, 
respectively. The average annual changes in the gender 
ratio of first and last authors were −1.5% and −2.6%, 
respectively (first author: incidence rate ratio (IRR) 0.98, 
95% CI 0.97 to 1.00, p value for trend=0.12; last author: 
IRR 0.97, 95% CI 0.96 to 0.99, p value for trend=0.001).
The analyses for gender pairs of first and last authors 
are shown in figures 3 and 4. Although men as both 
first and last authors was the most common, over time 
male–male pairs decreased by 2.0% (IRR 0.98, 95% CI 
0.98 to 0.99, p value for trend <0.001), and male–female 
and female–female pairs increased by 2.0% and 5.0%, 
respectively (IRR 1.02, 95% CI 1.01 to 1.03, p value for 
trend <0.001 and IRR 1.05, 95% CI 1.04 to 1.06, p value 
for trend <0.001, respectively).
In a sensitivity analysis, we compared the ratios with 
those of practising physicians in the USA. Women repre-
sent 33.3% and 27.2% of actively licensed physicians in 
haematology- oncology and radiation oncology, respec-
tively1 (online supplemental table 1 and figure 1). Our 
results indicate that the representation of women as first 
and last authors was comparable with the overall repre-
sentation of women as actively licensed physicians in 
oncology specialties in the USA. For every one increase 
in the number of coauthors, the odds of the first author 
being male are 1.04 (95% CI 1.03 to 1.05, p<0.001) and 
the odds of the last author being male are 1.07 (95% 
CI 1.06 to 1.08, p<0.001). The sensitivity analysis based 
on Q4 rank of oncology journal in PubMed in 2020 
(13 of 47 journals were retrievable in PubMed) showed 
consistent distribution of first and last authors by gender 
and gender combinations of first and last authors as 
presented in the main analysis (online supplemental 
table 2).
Finally, single- authored articles represented 2.8% of all 
articles (977 single- authored articles of 34 624 articles with 
available genders for first and last authors). The overall 
male to female ratio for single- authored articles was 2:1, 
while a decreasing pattern was found when analysing 
these data by year (online supplemental table 3).
DISCUSSION
We found that women were first authors of 33.6% arti-
cles. We also found evidence for continuously increasing 
representation of women as senior authors and authors 
of single- authored articles. The trend has been largely 
stable in recent years. However, disparity still exists, espe-
cially in the first author position. Female–female author 
pairs showed the most obvious increase relative to other 
gender pairings.
Our study results are largely consistent with prior studies 
that investigated female authorship in journals with high- 
impact factors, with some differences likely attributable 
to the averaging of multiple journals in our analysis. Dalal 
et al21 reported comparable increasing trends in female 
authorship in five major oncology journals between 1990 
and 2017. Their analysis included editorials, reviews, 
letters, notes and proceedings, in addition to original 
research articles. For the year 2017, the percentage of 
female senior authorship was nearly 10% lower than that 
of first authorship, which corroborated with our find-
ings.21 Ahmed et al15 examined trends in female author-
ship in the International Journal of Radiation Oncology, 
Biology, Physics between 1980 and 2012. For all original 
articles in 2012, they reported that 29.7% and 22.6% of 
first authors and last authors were women, respectively.15 
Although gender differences in medical research have 
been examined,2–5 22 our study is unique as we described 
the gender gap in original oncology research publica-
tions in 10 major medical journals over the last 18 years.
The number of female first authors was consistently 
lower than that of male first authors. Nearly one- third 
of actively licensed oncology physicians in the USA are 
women,1 and the annual increase in female oncologists 
is greater than that of male oncologists in many Euro-
pean countries.23 However, female oncologists are less 
likely to have leadership roles and feel that their gender 
is adversely affecting their career.23 The relative lack of 
female investigators publishing oncology topics is consis-
tent with the trend in gender differences in other research 
areas, despite an increase in women entering scientific 
careers.19 24 It is noteworthy that the proportion of US 
oncologists was used for comparison in the sensitivity 
analysis, but the gender findings were derived from liter-
ature by authors across the globe. Thus, this comparison 
should be at best considered as hypothesis- generating.
Simpson’s paradox may bias the interpretation of 
data on gender disparity in publication, including our 
results. This paradox implies that an apparent association 
between two variables can actually be the result of a joint 
dependency on a third variable.25 For example, a finding 
that female researchers succeeded less often in grant 
applications could be biased because women pursue 
funding more frequently in more competitive research 
fields, and the funded topics are under- represented in 
the analysed journals.25 Our results could also be related 
to self- selection of career paths; for example, fewer 
women choose to publish papers due to fewer opportu-
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time.26 Unfortunately, we did not have information about 
the number of submitted papers or the distribution of 
the topics accepted and rejected by journals, respectively. 
Additionally, women often have greater caregiving respon-
sibility, and work–family conflicts can be at odds with 
achieving academic outcomes.25 Further, positive presen-
tation of research findings is associated with higher rates 
of subsequent citations,8 which could drive differential 
recognition of accomplishments in women and men. A 
complex interaction of the above gender biases and poli-
cies can contribute to the under- representation of women 
in publication and in leadership positions.27 28 Finally, we 
were not able to examine this in our study but under- 
representation is much more pronounced for women 
from racial/ethnic minority groups. Future studies are 
warranted to fully understand the historical, structural, 
and institutional barriers that contribute to the chronic 
under- representation of these subgroups.
Figure 1 Gender ratios of first authors and last authors from 
2002 to 2019, all journals.
Figure 2 Gender ratios of first authors and last authors from 2002 to 2019. The top 4 journals (by number of articles) are 
shown because some of the other journals had zero cases for gender in some years. Int J Radiat Oncol Biol Phys, International 
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Our study has some imitations. First, our use of Gender 
API and choice of the 60% accuracy threshold represent 
a trade- off between the accuracy and the comprehen-
siveness of the data analysed. Second, gender inference 
algorithms currently only support gender binary classifi-
cation systems. Third, available information did not allow 
adjustment for some variables. For instance, H- index 
is not available for all authors; the rank of institutions 
could be difficult to adjust for because many articles were 
published by hospitals and laboratories, authors often 
have multiple affiliations and articles were sometimes 
written in non- standard formats. Fourth, we assumed that 
the first and last authors were oncologists, but the papers 
might actually have been written by other non- oncologist 
professionals. Finally, we assessed the gender compo-
sition of first and last authors on the assumption that 
these authorship positions are key positions in research 
activities and publication. Our analysis included only 
original research articles. Other important contributions 
in research projects including conference abstracts for 
presentation, database management, coding and analysis 
could not be assessed.
Overall, the variation between journals and time 
periods suggests the need and opportunity for continued 
efforts to support the advancement of women in 
oncology research. Strengthening existing initiatives 
and supporting new pipeline programmes are needed 
to address under- representation of female oncologists 
in leadership roles and promote equal access to career 
development opportunities. The proportion of single 
authorship by women in prestigious journals is smaller 
in contrast to men. We argue that initiatives to promote 
Figure 3 Temporal trends in percentage of original research 
articles published by female and male authors when paired 
by gender as first and last authors from 2002 to 2019, all 
journals.
Figure 4 Temporal trends in percentage of original research articles published by female and male authors when paired by 
gender as first and last authors from 2002 to 2019, by individual journals. Int J Radiat Oncol Biol Phys, International Journal of 
Radiation Oncology, Biology, Physics; JAMA, The Journal of the American Medical Association; J Clin Oncol, The Journal of 
Clinical Oncology; J Natl Cancer Inst, The Journal of the National Cancer Institute; Lancet Oncol, The Lancet Oncology; N Engl J 
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academic choices and careers of women at the student 
level more than focusing on journals or peer review must 
be developed. To objectively evaluate programmes aimed 
at addressing gender inequalities, collecting high- quality 
data will be critical.
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